Sally Santisteve

2 weeks ago | publications.ersnet.org | Jessica Gonzalez |Santa Maria |Ivan Benitez |Sally Santisteve

IntroductionSince the first case of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was detected, efforts have focused on generating large clinical cohorts of patients to gain the most knowledge possible to better understand coronavirus disease 2019 (COVID-19) [1]. This effort has been particularly important in the field of pulmonary sequelae after suffering acute respiratory distress syndrome (ARDS) [2–7].